Anna Eshoo actually said...

You have been the stars. Every Member here, every Member, has hung on every word that you have uttered.

Finally, there needs to be clarity and transparency about the standards for approval for deadly diseases with unmet medical needs.

So if FDA had a similar authority for a conditional approval pathway, would that give the FDA more flexibility in getting potentially promis...

We need better multidiscipline coordination between FDA, NIH, academic researchers, private drug companies, and patients.